Tower Research Capital (TRC)’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6
Closed -$154 5271
2024
Q4
$154 Hold
6
﹤0.01% 5412
2024
Q3
$337 Hold
6
﹤0.01% 5373
2024
Q2
$335 Hold
6
﹤0.01% 5353
2024
Q1
$433 Hold
6
﹤0.01% 5493
2023
Q4
$320 Hold
6
﹤0.01% 5609
2023
Q3
$362 Hold
6
﹤0.01% 5587
2023
Q2
$277 Sell
6
-3
-33% -$140 ﹤0.01% 5707
2023
Q1
$0 Buy
9
+3
+50% +$177 ﹤0.01% 5860
2022
Q4
$0 Hold
6
﹤0.01% 5940
2022
Q3
$0 Hold
6
﹤0.01% 6106
2022
Q2
$1K Hold
6
﹤0.01% 5754
2022
Q1
$1K Buy
+6
New +$890 ﹤0.01% 5759

Other funds holding CNBS

Tower Research Capital (TRC)'s CNBS Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Amplify Seymour Cannabis ETF (CNBS) in Q1 2025, closing a stake of 6 shares — an estimated $154 sold.

Tower Research Capital (TRC) first reported a position in CNBS in Q1 2022 and held it in 12 quarters. The position peaked at $1K in Q2 2022. 18 funds tracked by Wall St. Rank hold CNBS as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Amplify Seymour Cannabis ETF position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6 Amplify Seymour Cannabis ETF shares in Q1 2025, an estimated $154.
  • Tower Research Capital (TRC) first reported a position in Amplify Seymour Cannabis ETF in Q1 2022 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Amplify Seymour Cannabis ETF position peaked at $1K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.